Equifax (NYSE:EFX) Price Target Increased to $304.00 by Analysts at JPMorgan Chase & Co.

Equifax (NYSE:EFX) had its target price upped by JPMorgan Chase & Co. from $300.00 to $304.00 in a report released on Friday morning, Benzinga reports. The brokerage currently has an overweight rating on the credit services provider’s stock.

Several other research firms have also recently weighed in on EFX. Bank of America lifted their price target on shares of Equifax from $255.00 to $286.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Wolfe Research started coverage on shares of Equifax in a report on Tuesday, July 9th. They issued an “outperform” rating and a $275.00 price target on the stock. The Goldman Sachs Group lifted their price target on shares of Equifax from $277.00 to $307.00 and gave the company a “neutral” rating in a report on Tuesday, August 20th. Needham & Company LLC reiterated a “buy” rating and issued a $350.00 price target on shares of Equifax in a report on Friday. Finally, Wells Fargo & Company cut their price target on shares of Equifax from $375.00 to $350.00 and set an “overweight” rating on the stock in a report on Friday. Four analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $310.47.

Equifax Stock Performance

NYSE:EFX opened at $282.05 on Friday. The firm has a market cap of $34.86 billion, a PE ratio of 62.82, a price-to-earnings-growth ratio of 2.00 and a beta of 1.58. Equifax has a fifty-two week low of $159.95 and a fifty-two week high of $309.63. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.79 and a current ratio of 0.79. The business has a 50 day moving average price of $294.95 and a 200-day moving average price of $262.95.

Equifax (NYSE:EFX) last released its quarterly earnings data on Wednesday, October 16th. The credit services provider reported $1.85 earnings per share for the quarter, beating analysts’ consensus estimates of $1.84 by $0.01. The firm had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.44 billion. Equifax had a return on equity of 18.88% and a net margin of 10.67%. The business’s quarterly revenue was up 9.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.76 earnings per share. Equities research analysts predict that Equifax will post 7.36 earnings per share for the current year.

Equifax Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Tuesday, September 3rd were given a $0.39 dividend. This represents a $1.56 dividend on an annualized basis and a yield of 0.55%. The ex-dividend date was Tuesday, September 3rd. Equifax’s dividend payout ratio (DPR) is 34.74%.

Insiders Place Their Bets

In other Equifax news, EVP Carla Chaney sold 3,000 shares of the business’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $281.85, for a total value of $845,550.00. Following the completion of the transaction, the executive vice president now owns 10,875 shares of the company’s stock, valued at approximately $3,065,118.75. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.57% of the stock is owned by insiders.

Institutional Investors Weigh In On Equifax

Several hedge funds and other institutional investors have recently made changes to their positions in EFX. Price T Rowe Associates Inc. MD increased its position in shares of Equifax by 72.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,514,093 shares of the credit services provider’s stock valued at $405,051,000 after purchasing an additional 633,887 shares during the last quarter. Capital International Investors increased its position in shares of Equifax by 2.5% during the 1st quarter. Capital International Investors now owns 14,045,398 shares of the credit services provider’s stock valued at $3,757,425,000 after purchasing an additional 342,170 shares during the last quarter. Massachusetts Financial Services Co. MA increased its position in shares of Equifax by 4.9% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 4,276,798 shares of the credit services provider’s stock valued at $1,036,952,000 after purchasing an additional 200,665 shares during the last quarter. Ceredex Value Advisors LLC increased its position in shares of Equifax by 127.1% during the 2nd quarter. Ceredex Value Advisors LLC now owns 350,356 shares of the credit services provider’s stock valued at $84,947,000 after purchasing an additional 196,106 shares during the last quarter. Finally, Vanguard Group Inc. increased its position in shares of Equifax by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 14,033,448 shares of the credit services provider’s stock valued at $3,754,228,000 after purchasing an additional 137,961 shares during the last quarter. Hedge funds and other institutional investors own 96.20% of the company’s stock.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.